Avanos Medical (AVNS) Capital Expenditures (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118.61% |
| Dec 31, 2025 | -430.00% |
| Sep 30, 2025 | -36.36% |
| Jun 30, 2025 | 64.18% |
| Mar 31, 2025 | 190.54% |
| Dec 31, 2024 | -346.67% |
| Sep 30, 2024 | -49.15% |
| Jun 30, 2024 | 43.90% |
| Mar 31, 2024 | -30.51% |
| Dec 31, 2023 | 51.28% |
| Sep 30, 2023 | -2.50% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 138.10% |
| Dec 31, 2022 | -298.11% |
| Sep 30, 2022 | 29.27% |
| Jun 30, 2022 | -18.00% |
| Mar 31, 2022 | 146.73% |
| Dec 31, 2021 | -322.92% |
| Sep 30, 2021 | -17.24% |
| Jun 30, 2021 | 1.75% |
| Mar 31, 2021 | 148.72% |
| Dec 31, 2020 | -490.00% |
| Sep 30, 2020 | -56.52% |
| Jun 30, 2020 | 32.69% |
| Mar 31, 2020 | -35.80% |
| Dec 31, 2019 | 14.08% |
| Sep 30, 2019 | -69.00% |
| Jun 30, 2019 | 83.20% |
| Mar 31, 2019 | -29.38% |
| Dec 31, 2018 | 65.42% |
| Sep 30, 2018 | -3.60% |
| Jun 30, 2018 | 15.63% |
| Mar 31, 2018 | 136.78% |
| Dec 31, 2017 | -286.43% |
| Sep 30, 2017 | 118.75% |
| Jun 30, 2017 | -37.25% |
| Mar 31, 2017 | 164.15% |
| Dec 31, 2016 | -309.21% |
| Sep 30, 2016 | 24.59% |
| Jun 30, 2016 | -23.75% |
| Mar 31, 2016 | 113.61% |
| Dec 31, 2015 | -406.25% |
| Sep 30, 2015 | 9.71% |
| Jun 30, 2015 | -36.82% |
| Mar 31, 2015 | 171.21% |
| Dec 31, 2014 | -220.06% |
| Sep 30, 2014 | 58.05% |
| Jun 30, 2014 | 173.33% |
| Mar 31, 2014 | 119.79% |